Literature DB >> 19026342

Neuroprotection in infant heart surgery.

Robert Ryan Clancy1.   

Abstract

Neonatal hypoxic-ischemic encephalopathy, prematurity, sepsis-meningitis, and serious forms of complex congenital heart disease requiring infant heart surgery are just a few examples of disorders that share high mortality and morbidity rates. Newborn heart surgery represents a period of planned and deliberate ischemia-reperfusion injury, which is obliged to occur to cure or palliate complex forms of congenital heart disease. Advances in cardiothoracic surgical and anesthetic techniques, including cardiopulmonary bypass and deep hypothermic circulatory arrest, have substantially decreased mortality, expanding the horizon to address functional neurologic and cardiac outcomes in long-term survivors. Interest in the functional status of survivors now stretches beyond the newborn period to childhood, adolescence, and adulthood.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19026342     DOI: 10.1016/j.clp.2008.07.008

Source DB:  PubMed          Journal:  Clin Perinatol        ISSN: 0095-5108            Impact factor:   3.430


  4 in total

Review 1.  New approaches to neuroprotection in infant heart surgery.

Authors:  Erin L Albers; David P Bichell; Bethann McLaughlin
Journal:  Pediatr Res       Date:  2010-07       Impact factor: 3.756

Review 2.  Treatment advances in neonatal neuroprotection and neurointensive care.

Authors:  Michael V Johnston; Ali Fatemi; Mary Ann Wilson; Frances Northington
Journal:  Lancet Neurol       Date:  2011-04       Impact factor: 44.182

3.  Short-term neurodevelopmental outcomes in neonates with congenital heart disease: the era of newer surgical strategies.

Authors:  Valerie Y Chock; Irene J Chang; V Mohan Reddy
Journal:  Congenit Heart Dis       Date:  2012-06-08       Impact factor: 2.007

4.  Perioperative plasma F(2)-Isoprostane levels correlate with markers of impaired ventilation in infants with single-ventricle physiology undergoing stage 2 surgical palliation on the cardiopulmonary bypass.

Authors:  Erin Albers; Brian S Donahue; Ginger Milne; Benjamin R Saville; Wenli Wang; David Bichell; BethAnn McLaughlin
Journal:  Pediatr Cardiol       Date:  2012-02-12       Impact factor: 1.655

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.